XLV
Health Care Select Sector SPDR
ETF / Index
Price today
$159.95
Recent high
$165.61
-3.4% from high · cheap vs its own history
charlieapp.co
Index ETFs don't have their own calculated Value. They hold hundreds of companies — we work out whether the group is expensive or cheap versus its history.
From high
-3%
all-time high
Cycle low
$97.51
historic floor
Premium
+64%
above the low
Current cycle zone
You are 3% below the all-time high, and 64% above the low of the cycle. The signal comes from where you sit in that range.
The floor of the cycle is at $97.51; the ceiling, at $165.61. The closer to the floor, the better the spot to build in slowly.
It has no intrinsic value from fundamentals — the range comes from price highs and lows. The final call is yours; buying gradually (DCA) means a little at a time.
The business
A single basket to get exposure to the sector that takes care of millions of people's health.
XLV is an exchange-traded fund (ETF) that tracks the healthcare sector within the index of large U.S. companies. It gathers into one basket companies from pharmaceuticals, medical equipment, health insurance, and hospital services. When you buy a share, you indirectly own a little piece of many of those companies at once.
Its advantage as a vehicle is giving you diversified exposure to an entire key sector at a low annual cost and with great ease to buy and sell, something hard to put together on your own company by company.
Catalysts and risks
The aging population in developed countries, which structurally increases demand for treatments and care.
Constant innovation in medicines, biotech, and medical equipment, which opens new revenue streams.
The sector's defensive nature: people keep needing healthcare even when the economy cools, which tends to attract investment flows in times of uncertainty.
Concentration: a few large companies tend to carry a lot of weight within the basket, so a stumble by them affects the whole fund.
Regulatory and political risk: changes in drug pricing rules or in health insurance can hit the entire sector.
Even though the annual fee is low, it still exists and is deducted over time; plus the sector can go through long stretches without advancing.
Charlie's note
“More than guessing the exact moment to enter, what adds up over time is the discipline of contributing little by little and keeping a low cost. It's worth looking at where it stands today relative to its historical ups and downs rather than buying out of enthusiasm.”
Analysis · June 2026
Charlie informs, it doesn't advise. No information should be taken as a recommendation to buy or sell.